Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8791860 | Experimental Eye Research | 2018 | 24 Pages |
Abstract
Our initial findings showed that when treated with bevacizumab and ranibizumab, both AMD cybrids and age-matched normal cybrids had a significant decrease in bead-uptake. A similar decrease in bead-uptake was found in normal cybrids treated with aflibercept and while the AMD values trended lower, they were not significant. This data suggests that anti-VEGF drugs can cause loss of phagocytic function.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Thomas A. Vo, Sina Abedi, Kevin Schneider, Marilyn Chwa, M. Cristina Kenney,